Spark Ventures

Mirada Solutions

Biological therapies:

 

Celldex Therapeutics, Inc.

 

GlycArt AG

 

Glycoform

 

Haemostatix

 

Oxford BioMedica plc

 

Oxitec

Diagnostics & point-of-care:

 

IDG

 

Oxford Biosensors

 

Oxford Immunotec

 

Vivacta Limited

Disease Management & wellness:

 

Gemini Biomedical

 

Genosis plc

Instrumentation:

 

Teraview

IT in Healthcare:

 

Mirada Solutions

Medical Devices & Medical Technology:

 

(No investments to date)

Nanotechnology:

 

Oxonica plc

Pharmaceuticals and Speciality pharmaceuticals:

 

Allergy Therapeutics plc

 

Cyclacel Inc

 

Lectus Therapeutics

 

Medigene AG

 

Oxagen

 

PowerMed

 

Sterix

 

Vernalis plc

 

Xention

Telemedicine & e-Health:

 

(No investments to date)

 
Sale to CTI Molecular Imaging

 

Mirada Solutions Limited is a leading developer of software and analytical tools for medical imaging workstations. Mirada's unique products aid better detection, diagnosis and management of disease through the application of powerful image analysis tools to medical images.

Originally formed in 2000 when spin-out companies OXIVA and OMIA merged, Mirada was acquired by CTI Molecular Imaging Inc in August 2003 which was in time acquired by Siemens in 2005.

© 2013 SPARK Ventures |